Direktorat Registrasi ObatValid

XIGDUO XR

BPOM Number: DKI1827900217D1
Approved: 21 November 2024
Expiry: 18 June 2028
Form: TABLET SALUT SELAPUT; 12,30 MG /1005,04 MG

About This Registration

XIGDUO XR is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1827900217D1. Its current registration status is Valid, with the licence valid until 18 June 2028. The product is registered to ASTRAZENECA INDONESIA - INDONESIA. BPOM first approved this registration in June 2023. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 4 BLISTER @ 7 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

ASTRAZENECA INDONESIA - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

ASTRAZENECA INDONESIA - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

DAPAGLIFLOZIN PROPANEDIOL. METFORMIN HYDROCHLORIDE

Market Intelligence

Owner Portfolio: ASTRAZENECA INDONESIA - INDONESIA holds 105 BPOM registrations
Manufacturer Scale: ASTRAZENECA INDONESIA - INDONESIA produces 105 registered products
Registration Age: Registered for 3 years, 3 months